Autonomic drugs in the treatment of canine and feline glaucoma – Part II: Medications that lower intraocular pressure by reducing aqueous humour production

• Autorzy: Maslanka T.
• Języki publikacji: EN

Abstrakty

EN

One characteristic of the most common types of glaucoma is increased intraocular pressure (IOP), which has a damaging effect on optic nerve axons, leading to progressive loss of retinal ganglion cells. Therefore, ocular hypotensive drugs are the mainstay of pharmacological therapy for glaucoma. This review article, which is the second part of a two-part series, is dedicated to autonomic drugs which lower IOP by decreasing the aqueous humour production. These agents are subdivided into two groups: β-adrenergic antagonists and selective α2-adrenergic agonists. This paper summarizes the current state of knowledge on the mechanism of action of these drugs and their effect on IOP in dogs and cats. Moreover, it discusses their possible undesirable side effects of these medications and presents the current ideas about their role and position in the medical management of glaucoma in small animals.

• Wydawca: -
• Czasopismo: Polish Journal of Veterinary Sciences
• Rocznik: 2014
• Tom: 17
• Numer: 4
• Opis fizyczny: p.753-763,fig.,ref.

Twórcy

autor

Maslanka T.

• Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Oczapowskiego 13, 10-718 Olsztyn, Poland

Bibliografia

• Allen RC, Langham ME (1976) The intraocular pressure response of conscious rabbits to clonidine. Invest Ophthalmol 15: 815-823.
• Bartlett JD, Fiscella RG, Jaanus SD, Barnebey H (2008) Ocular hypotensive drugs. In: Bartlett JD, Jaanus SD (eds) Clinical ocular pharmacology. Butterworth-Heinemann, St. Louis, pp 139-174.
• Bartels SP, Lee SR, Neufeld AH (1987) The effects of forskolin on cyclic AMP, intraocular pressure and aqueous humor formation in rabbits. Curr Eye Res 6: 307-320.
• Bartels SP, Roth HO, Jumblatt MM, Neufeld AH (1980) Pharmacological effects of topical timolol in the rabbit eye. Invest Ophthalmol Vis Sci 19: 1189-1197.
• Boas RS, Messenger MJ, Mittag TW, Podos SM (1981) The effects of topically applied epinephrine and timolol on intraocular pressure and aqueous humor cyclic-AMP in the rabbit. Exp Eye Res 32: 681-690.
• Boger WP 3rd, Puliafito CA, Steinert RF, Langston DP (1978a) Long-term experience with timolol ophthalmic solution in patients with open-angle glaucoma. Ophthalmology 85: 259-267.
• Boger WP 3rd, Steinert RF, Puliafito CA, Pavan-Langston D (1978b) Clinical trial comparing timolol ophthalmic solution to pilocarpine in open-angle glaucoma. Am J Ophthalmol 86: 8-18.
• Bonomi I, Steindler P (1975) Effect of pindolol on intraocular pressure. Br J Ophthalmol 59: 301-303.
• Bromberg BB, Gregory DS, Sears ML (1980) Beta-adrenergic receptors in ciliary processes of the rabbit. Invest Ophthalmol Vis Sci 19: 203-207.
• Bucci MG, Missiroli A, Pecori Giraldi J, Virno M (1968) The local administration of propranolo in the therapy of glaucoma. Boll Ocul 47: 51-60.
• Burke JA, Potter DE (1986) Ocular effects of a relatively selective alpha 2 agonist (UK-14, 304-18) in cats, rabbits and monkeys. Curr Eye Res 5: 665-676.
• Burke J, Schwartz M (1996) Preclinical evaluation of brimonidine. Surv Ophthalmol 41 (Suppl 1): 9-18.
• Butler P, Mannschreck M, Lin S, Hwang I, Alvarado J (1995) Clinical experience with the long-term use of 1% apraclonidine. Incidence of allergic reactions. Arch Ophthalmol 113: 293-296.
• Camras CB, Podos SM (1989) The Role of Endogenous Prostaglandins in Clinically-Used and Investigational Glaucoma Therapy. In: Bito LZ, Stjernschantz J (eds) The ocular effects of prostaglandins and other eicosanoids. Alan R Liss Inc, New York, pp 459-475.
• Caprioli J, Sears M, Bausher L, Gregory D, Mead A (1984) Forskolin lowers intraocular pressure by reducing aqueous inflow. Invest Ophthalmol Vis Sci 25: 268-277.
• Civan MM (2008) Formation of the aqueous humor: transport components and their integration. In: Civian M (ed) The Eye’s Aqueous Humor. Elsevier Inc, San Diego, pp 2-33.
• Coakes RL, Brubaker RF (1978) The mechanisms of timolol in lowering intraocular pressure. In the normal eye. Arch Ophthalmol 96: 2045-2048.
• Coakes RL, Mackie IA, Seal DV (1981) Effects of long-term treatment with timolol on lacrimal gland function. Br J Ophthalmol 65: 603-605.
• Coakes RL, Siah PB (1984) Effects of adrenergic drugs on aqueous humour dynamics in the normal human eye. I. Salbutamol. Br J Ophthalmol 68: 393-397.
• Colasanti BK, Trotter RR (1981) Effects of selective beta 1- and beta 2-adrenoreceptor agonists and antagonists on intraocular pressure in the cat. Invest Ophthalmol Vis Sci 20: 69-76.
• Coleman AL, Robin AL, Pollack IP (1989) New ophthalmic drugs: apraclonidine hydrochloride. Ophthalmol Clin North Am 2: 97-108.
• Crook RB, Riese K (1996) Beta-adrenergic stimulation of Na+, K+, Cl- cotransport in fetal nonpigmented ciliary epithelial cells. Invest Ophthalmol Vis Sci 37: 1047-1057.
• Crosson CE, Heath AR, DeVries GW, Potter DE (1992) Pharmacological evidence for heterogeneity of ocular alpha 2 adrenoceptors. Curr Eye Res 11: 963-970.
• Dailey RA, Brubaker RF, Bourne WM (1982) The effects of timolol maleate and acetazolamide on the rate of aqueous formation in normal human subjects. Am J Ophthalmol 93: 232-237.
• Dietrich UM, Chandler MJ, Cooper T, Vidyashankar A, Chen G (2007) Effects of topical 2% dorzolamide hydrochloride alone and in combination with 0.5% timolol maleate on intraocular pressure in normal feline eyes. Vet Ophthalmol 10 (Suppl 1): 95-100.
• Elena PP, Moulin G, Lapalus P (1984) Characterization of beta adrenergic receptors in bovine pigmented ciliary processes. Curr Eye Res 3: 743-750.
• Gabelt BT, Robinson JC, Hubbard WC, Peterson CM, Debink N, Wadhwa A, Kaufman PL (1994) Apraclonidine and brimonidine effects on anterior ocular and cardiovascular physiology in normal and sympathectomized monkeys. Exp Eye Res 59: 633-644.
• Gelatt KN, Brooks DE, Kallberg ME (2007) The canine glaucomas. In: Gelatt KN (ed) Veterinary Ophthalmology. Blackwell Publishing, Oxford, pp 753-811.
• Gelatt KN, Larocca RD, Gelatt JK, Strubbe DT, MacKay EO (1995) Evaluation of multiple doses of 4 and 6% timolol, and timolol combined with 2% pilocarpine in clinically normal beagles and beagles with glaucoma. Am J Vet Res 56: 1325-1331.
• Gelatt KN, MacKay EO (2002) Effect of single and multiple doses of 0.2% brimonidine tartrate in the glaucomatous Beagle. Vet Ophthalmol 5: 253-262.
• Gharagozloo NZ, Brubaker RF (1991) Effect of apraclonidine in long-term timolol users. Ophthalmology 98: 1543-1546.
• Gharagozloo NZ, Larson RS, Kullerstrand LJ, Brubaker RF (1988a) Terbutaline stimulates aqueous humor flow in humans during sleep. Arch Ophthalmol 106: 1218-1220.
• Gharagozloo NZ, Relf SJ, Brubaker RF (1988b) Aqueous flow is reduced by the alpha-adrenergic agonist, apraclonidine hydrochloride (ALO 2145). Ophthalmology 95: 1217-1220.
• Gum GC, Larocca RD, Gelatt KN, Mead JP, Gelatt JK (1991) The effect of topical timolol maleate on intraocular pressure in normal beagles and beagles with inherited glaucoma. Prog Vet Comp Ophthalmol 1: 141-150.
• Harrison R, Kaufmann CS (1977) Clonidine: Effects of a topically administered solution on intraocular pressure and blood pressure in open-angle glaucoma. Arch Ophthalmol 95: 1368-1373.
• Hasslinger R (1969) Catapres: a new drug lowering intraocular pressure. Klin Monatsbl Augenheilkd 154: 95-105.
• Helal J, Macri FJ, Cevario SJ (1979) Timolol inhibition of aqueous humor production in the cat. Gen Pharmacol 10: 377-380.
• Higginbotham EJ, Diestelhorst M, Pfeiffer N, Rouland JF, Alm A (2002) The efficacy and safety of unfixed and fixed combinations of latanoprost and other antiglaucoma medications. Surv Ophthalmol 47 (Suppl 1): 133-140.
• Hikasa Y, Akiba T, Iino Y, Matsukura M, Takase K, Ogasawara S (1992) Central alpha-adrenoceptor subtypes involved in the emetic pathway in cats. Eur J Pharmacol 229: 241-251.
• HuangY, GilDW, Vanscheeuwijck P, StamerWD, Regan JW (1995) Localization of alpha 2-adrenergic receptor subtypes in the anterior segment of the human eye with selective antibodies. Invest Ophthalmol Vis Sci 36: 2729-2739.
• Jumblatt JE, Liu JG, North GT (1987) Alpha-2 adrenergic modulation of norepinephrine secretion in the perfused rabbit iris-ciliary body. Curr Eye Res 6: 767-777.
• Juzych MS, Zimmerman TJ, Robin AL (1997) Update on adrenergic agents in glaucoma. Ophthalmol Clin North Am 10: 309-325.
• Katz IM, Hubbard WA, Getson AJ, Gould AL (1976) Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution. Invest Ophthalmol 15: 489-492.
• Kintz P, Himber J, de Burlet G, Andermann G (1988) Characterization of alpha 2-adrenergic receptors, negatively coupled to adenylate cyclase, in rabbit ciliary processes. Curr Eye Res 7: 287-292.
• Kubo C, Suzuki R (1992) Involvement of prejunctional alpha 2-adrenoceptor in bovine ciliary muscle movement. J Ocul Pharmacol 8: 225-231.
• Larsson LI (2001) Aqueous humor flow in normal human eyes treated with brimonidine and timolol, alone and in combination. Arch Ophthalmol 119: 492-495.
• Lee DA, Topper JE, Brubaker RF (1984) Effect of clonidine on aqueous humor flow in normal human eyes. Exp Eye Res 38: 239-246.
• Liu JH, Bartels SP, Neufeld AH (1984) Effects of timolol on intraocular pressure following ocular adrenergic denervation. Curr Eye Res 3: 1113-1117.
• Liu HK, Chiou GC, Garg LC (1980) Ocular hypotensive effects of timolol in cat eyes. Arch Ophthalmol 98: 1467-1469.
• Macknight ADC, Civan MM (2008) Regional dependence of inflow: lessons from electron probe X-ray microanalysis. In: CivanM (ed) The Eye’s Aqueous Humor. Elsevier Inc, San Diego, pp 98-119.
• Marquis RE, Whitson JT (2005) Management of glaucoma: focus on pharmacological therapy. Drugs Aging 22: 1-21.
• Mayor-Torroglosa S, De la Villa P, Rodrtguez ME, López-Herrera MP, Avile´s-Trigueros M, Garcáa-Avilés A, de Imperial JM, Villegas-Pérez MP, Vidal-Sanz M (2005) Ischemia results 3 months later in altered ERG, degeneration of inner layers, and deafferented tectum: neuroprotection with brimonidine. Invest Ophthalmol Vis Sci 46: 3825-3835.
• McCannel CA, Heinrich SR, Brubaker RF (1992) Acetazolamide but not timolol lowers aqueous humor flow in sleeping humans. Graefes Arch Clin Exp Ophthalmol 230: 518-520.
• McLellan GJ, Miller PE (2011) Feline glaucoma - a comprehensive review. Vet Ophthalmol 14: (Suppl 1) 15-29.
• McMahon CD, Shaffer RN, Hoskins HD Jr, Hetherington J Jr (1979) Adverse effects experienced by patients taking timolol. Am J Ophthalmol 88: 736-738.
• Maehara S, Ono K, Ito N, Tsuzuki K, Seno T, Yokoyama T, Yamashita K, Izumisawa Y, Kotani T (2004) Effects of topical nipradilol and timolol maleate on intraocular pressure, facility of outflow, arterial blood pressure and pulse rate in dogs. Vet Ophthalmol 7: 147-150.
• Makabe R (1966) Ophthalmological studies with dichlorophenylaminoimidazoline with special regard to its effect on intraocular pressure. Dtsch Med Wochenschr 91: 1686-1688.
• Martin CL (2010) Glaucoma. In: Martin CL (ed) Ophthalmic diseases in veterinary medicine. Manson Publishing Ltd, London, pp 337-364.
• Maus TL, Nau C, Brubaker RF (1999) Comparison of the early effects of brimonidine and apraclonidine as topical ocular hypotensive agents. Arch Ophthalmol 117: 586-591.
• Miichi H, Nagataki S (1983) Effects of pilocarpine, salbutamol, and timolol on aqueous humor formation in cynomolgus monkeys. Invest Ophthalmol Vis Sci 24: 1269-1275.
• Miller PE (2008) Glaucoma. In: Maggs DJ, Miller PE, Ofri R (eds) Slatter’s Fundamentals of Veterinary Ophthalmology. Saunders Elsevier, St Louis, pp 230-257.
• Miller PE, Nelson MJ, Rhaesa SL (1996) Effects of topical administration of 0.5% apraclonidine on intraocular pressure, pupil size, and heart rate in clinically normal dogs. Am J Vet Res 57: 79-82.
• Miller PE, Rhaesa SL (1996) Effects of topical administration of 0.5% apraclonidine on intraocular pressure, pupil size, and heart rate in clinically normal cats. Am J Vet Res 57: 83-86.
• Miller PE, Schmidt GM, Vainisi SJ, Swanson JF, Herrmann MK (2000) The efficacy of topical prophylactic antiglaucoma therapy in primary closed angle glaucoma in dogs: a multicenter clinical trial. J Am Anim Hosp Assoc 36: 431-438.
• Mittag TW, Tormay A (1985) Drug responses of adenylate cyclase in iris-ciliary body determined by adenine labelling. Invest Ophthalmol Vis Sci 26: 396-399.
• Musini A, Fabbri B, Bergamaschi M, Mandelli V, Shanks RG (1971) Comparison of the effect of propranolol, lignocaine, and other drugs on normal and raised intraocular pressure in man. Am J Ophthalmol 72: 773-781.
• Nathanson JA (1980) Adrenergic regulation of intraocular pressure: identification of beta 2-adrenergic-stimulated adenylate cyclase in ciliary process epithelium. Proc Natl Acad Sci U S A 77: 7420-7424.
• Petersen-Jones SM, Stanley R (2009) Ocular discharge. In: Peiffer RL, Petersen-Jones SM (eds) Small Animal Ophthalmology: A Problem-Oriented Approach. Saunders, St Louis, pp 253-293.
• Phillips CI, Howitt G, Rowlands DJ (1967) Propranolol as ocular hypotensive agent. Br J Ophthalmol 51: 222-226.
• Plummer CE, MacKay EO, Gelatt KN (2006) Comparison of the effects of topical administration of a fixed combination of dorzolamide-timolol to monotherapy with timolol or dorzolamide on IOP, pupil size, and heart rate in glaucomatous dogs. Vet Ophthalmol 9: 245-249.
• Reiss GR, Brubaker RF (1983) The mechanism of betaxolol, a new ocular hypotensive agent. Ophthalmology 90: 1369- -1372.
• Reiss GR, Lee DA, Topper JE, Brubaker RF (1984) Aqueous humor flow during sleep. Invest Ophthalmol Vis Sci 25: 776-778.
• Reynolds AC (2009) Alpha agonists. In: Shaarawy TM, Sherwood MB, Hitchings RA, Crowston JG (eds) Glaucoma Volume 1: Medical Diagnosis and Therapy. Saunders Elsevier, Philadelphia, pp 547-557.
• Saylor M, McLoon LK, Harrison AR, Lee MS (2009) Experimental and clinical evidence for brimonidine as an optic nerve and retinal neuroprotective agent: an evidence- based review. Arch Ophthalmol 127: 402-406.
• Schadlu R, Maus TL, Nau CB, Brubaker RF (1998) Comparison of the efficacy of apraclonidine and brimonidine as aqueous suppressants in humans. Arch Ophthalmol 116: 1441-1444.
• Shahidullah M, Wilson WS, Millar C (1995) Effects of timolol, terbutaline and forskolin on IOP, aqueous humour formation and ciliary cyclic AMP levels in the bovine eye. Curr Eye Res 14: 519-528.
• Smith LN, Miller PE, Felchle LM (2010) Effects of topical administration of latanoprost, timolol, or a combination of latanoprost and timolol on intraocular pressure, pupil size, and heart rate in clinically normal dogs. Am J Vet Res 71: 1055-1061.
• Sonntag JR, Brindley GO, Shields MB, Arafat NI, Phelps CD (1979) Timolol and epinephrine. Comparisin of efficacy and side effects. Arch Ophthalmol 97: 273-277.
• Stamper RL, Lieberman MF, Drake MV (2009) Medical treatment. In: Becker-Shaffer’s Diagnosis and Therapy of the Glaucomas. Mosby Elsevier, St. Louis, pp 359-435.
• Sugimoto A, Ikeda H, Tsukamoto H, Kihira K, Ishioka M, Hirose J, Hata T, Fujioka H, Ono Y (2010) Timolol activates the enzyme activities of human carbonic anhydrase I and II. Biol Pharm Bull 33: 301-306.
• Takase M (1976) Effects of topical isoproterenol and propranolol on flow rate of aqueous in rhesus monkey. Nippon Ganka Gakkai Zasshi 80: 379-384.
• Tieri O, Polzella A (1975) Clinical use and action mechanism of propranolol. Ophthalmologica 170: 36-42.
• Toris CB (2010) Pharmacotherapies for glaucoma. Curr Mol Med 10: 824-840.
• Toris CB, Gleason ML, Camras CB, Yablonski ME (1995a) Effects of brimonidine on aqueous humor dynamics in human eyes. Arch Ophthalmol 113: 1514-1517.
• Toris CB, Tafoya ME, Camras CB, Yablonski ME (1995b Effects of apraclonidine on aqueous humor dynamics in human eyes. Ophthalmology 102: 456-461.
• Topper JE, Brubaker RF (1985) Effects of timolol, epinephrine, and acetazolamide on aqueous flow during sleep. Invest Ophthalmol Vis Sci 26: 1315-1319.
• Tsukamoto H, Larsson LI (2004) Aqueous humor flow in normal human eyes treated with brimonidine and dorzolamide, alone and in combination. Arch Ophthalmol 122: 190-193.
• Wax MB, Molinoff PB (1987) Distribution and properties of beta-adrenergic receptors in human iris-ciliary body. Invest Ophthalmol Vis Sci 28: 420-430.
• WoldeMussie E, Ruiz G, Wijono M, Wheeler LA (2001) Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension. Invest Ophthalmol Vis Sci 42: 2849-2855.
• Yablonski ME, Zimmerman TJ, Waltman SR, Becker B (1978) A fluorophotometric study of the effect of topical timolol on aqueous humor dynamics. Exp Eye Res 27: 135-142.
• Yoles E, Wheeler LA, Schwartz M (1999) Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Invest Ophthalmol Vis Sci 40: 65-73.
• Watanabe K, Chiou GC (1983) Action mechanism of timolol to lower the intraocular pressure in rabbits. Ophthalmic Res 15: 160-167.
• Wayman L, Larsson LI, Maus T, Alm A, Brubaker R (1997) Comparison of dorzolamide and timolol as suppressors of aqueous humor flow in humans. Arch Ophthalmol 115: 1368-1371.
• Welch SL, Richardson JA (2002) Clinical effects of brimonidine ophthalmic drops ingestion in 52 dogs. Vet Hum Toxicol 44: 34-35.
• Wilkie DA, Latimer CA (1991a) Effects of topical administration of timolol maleate on intraocular pressure and pupil size in dogs. Am J Vet Res 52: 432-435.
• Wilkie DA, Latimer CA (1991b) Effects of topical administration of timolol maleate on intraocular pressure and pupil size in cats. Am J Vet Res 52: 436-440.
• Willis AM (2004) Ocular hypotensive drugs. Vet Clin North Am Small Anim Pract 34: 755-776.
• Zadok D, Geyer O, Zadok J, Lazar M, Krakowski D, Nemet P (1994) Combined timolol and pilocarpine vs pilocarpine alone and timolol alone in the treatment of glaucoma. Am J Ophthalmol 117: 728-731.
• Zimmerman TJ, Harbin R, Pett M, Kaufman HE (1977) Timolol and facility of outflow. Invest Ophthalmol Vis Sci 16: 623-624.
• Zimmerman TJ, Kaufman HE (1977) Timolol, Dose response and duration of action. Arch Ophthalmol 95: 605-607.

Identyfikatory

DOI

10.2478/pjvs-2014-0111